35,490 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Point72 Europe London LLP
Point72 Europe London LLP acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 35,490 shares of the biopharmaceutical company’s stock, valued at approximately $2,875,000. Several other […]
More Stories
Wall Street Review: Small Caps Outperform as Bond Yields Ease
By Panos Mourdoukoutas Small-cap stocks outperformed this week as investors rotated out of the volatile AI trade and into interest-rate-sensitive...
Judge Rejects Bail for Former OpenAI Employee Accused of Installing Listening Device
By Lear Zhou SAN FRANCISCO—A federal judge rejected a bail request of a former OpenAI engineer who was accused of...
Trump Announces $4.2 Billion Audi Auto Manufacturing Investment in Georgia
By Travis Gillmore PERRY, Ga.– President Donald Trump unveiled a $4.2 billion investment from automaker Audi to develop its first...
DOJ Gives California County Election Officials 48 Hours to Help Verify Voters’ Citizenship
By Tom Gantert The U.S. Department of Justice has sent letters to county election officials in California warning them they...
French Officials Say 1,300 Arrests Made Amid Latest Unrest
By Jack Phillips More than 1,300 people were arrested in another day of protests and riots, after a mass march...
RFK Jr. Announces American-Made Seafood Label at Midterm Rally in Florida
By Troy Myers Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has announced a new American-made label for...